Paper37598147
Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade.
Li J and 17 others. J Nanobiotechnology, 2023. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade. Papers, record 37598147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37598147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| NF-kappa B | Major topic |
| Arthritis | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Terpenes | |
| Macrophages |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82002267 | National Natural Science Foundation of China | PubMed | ||
| 82172349 | National Natural Science Foundation of China | PubMed | ||
| 82172385 | National Natural Science Foundation of China | PubMed | ||
| RCBS20200714114909007 | the Shenzhen Science and Technology Program | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 37726755 | Correction: Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade. | https://conductscience.org/library/papers/37726755 |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29362467 | Moving towards a molecular taxonomy of autoimmune rheumatic diseases. | Nat Rev Rheumatol | 2018 | https://conductscience.org/library/papers/29362467 | PubMed |
| 2 | 30408582 | Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. | Autoimmun Rev | 2019 | https://conductscience.org/library/papers/30408582 | PubMed |
| 3 | 30617265 | Cell migration: implications for repair and regeneration in joint disease. | Nat Rev Rheumatol | 2019 | https://conductscience.org/library/papers/30617265 | PubMed |
| 4 | 31735552 | Pharmacological blockade of PCAF ameliorates osteoarthritis development via dual inhibition of TNF-α-driven inflammation and ER stress. | EBioMedicine | 2019 | https://conductscience.org/library/papers/31735552 | PubMed |
| 5 | 30216660 | PCAF fine-tunes hepatic metabolic syndrome, inflammatory disease, and cancer. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/30216660 | PubMed |
| 6 | 30404815 | Sublytic C5b-9 Induces IL-23 and IL-36a Production by Glomerular Mesangial Cells via PCAF-Mediated KLF4 Acetylation in Rat Thy-1 Nephritis. | J Immunol | 2018 | https://conductscience.org/library/papers/30404815 | PubMed |
| 7 | 12419806 | Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12419806 | PubMed |
| 8 | 26238217 | Helicobacter pylori cytotoxin-associated gene A activates tumor necrosis factor-α and interleukin-6 in gastric epithelial cells through P300/CBP-associated factor-mediated nuclear factor-κB p65 acetylation. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/26238217 | PubMed |
| 9 | 32637751 | Substrate stiffness modulates bone marrow-derived macrophage polarization through NF-κB signaling pathway. | Bioact Mater | 2020 | https://conductscience.org/library/papers/32637751 | PubMed |
| 10 | 33768642 | P300/CBP-associated factor (PCAF) attenuated M1 macrophage inflammatory responses possibly through KLF2 and KLF4. | Immunol Cell Biol | 2021 | https://conductscience.org/library/papers/33768642 | PubMed |
| 11 | 30200762 | Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach. | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/30200762 | PubMed |
| 12 | 32327746 | Translating IL-6 biology into effective treatments. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32327746 | PubMed |
| 13 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 14 | 30372041 | Conducting Nanomaterial Sensor Using Natural Receptors. | Chem Rev | 2019 | https://conductscience.org/library/papers/30372041 | PubMed |
| 15 | 33351586 | Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals. | ACS Nano | 2021 | https://conductscience.org/library/papers/33351586 | PubMed |
| 16 | 28371624 | Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. | Biomaterials | 2017 | https://conductscience.org/library/papers/28371624 | PubMed |
| 17 | 35119317 | Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. | Drug Deliv | 2022 | https://conductscience.org/library/papers/35119317 | PubMed |
| 18 | 34125371 | Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway. | Sci China Life Sci | 2022 | https://conductscience.org/library/papers/34125371 | PubMed |
| 19 | 32965124 | Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways. | Nano Lett | 2020 | https://conductscience.org/library/papers/32965124 | PubMed |
| 20 | 30257408 | Garcinol exerts anti-cancer effect in human cervical cancer cells through upregulation of T-cadherin. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/30257408 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953335 | Spatiotemporally stratified nanoassemblies for precisely halting the immunothrombotic vicious cycle in acute lung inflammation. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/42953335 | PubMed |
| 42888460 | Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies. | Biomark Res | 2026 | https://conductscience.org/library/papers/42888460 | PubMed |
| 42764426 | Skin Aging: From Molecular Mechanisms to Therapeutic and Technological Innovations. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42764426 | PubMed |
| 42695407 | Research progress on lysine acetylation (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42695407 | PubMed |
| 42686689 | Macrophage-driven pathological ossification of the posterior longitudinal ligament: mechanistic insights and therapeutic opportunities. | Bone Res | 2026 | https://conductscience.org/library/papers/42686689 | PubMed |
| 41732378 | Neuro-bone-skin tri-regeneration via a microenvironment-responsive PRP-loaded chitosan hydrogel for traumatic brain injury therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41732378 | PubMed |
| 41562074 | The multifaceted role of post-translational modifications in macrophage polarization: from mechanisms to therapeutic targets. | Front Immunol | 2025 | https://conductscience.org/library/papers/41562074 | PubMed |
| 41522338 | Decoding Epigenetic Switches: How Histone Acetylation/Deacetylation Regulates Mononuclear/Macrophage Fate in Bone Disorders. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/41522338 | PubMed |
| 41492644 | NO-driven self-propelled nanomotors with deep biofilm penetration for synergistic therapy of peri-implantitis. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41492644 | PubMed |
| 41459510 | Macrophage polarization: molecular mechanisms, disease implications, and targeted therapeutic strategies. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459510 | PubMed |
| 41291215 | Monocyte/macrophage-derived NLRP3 Promotes the Onset and Progression of Ankylosing Spondylitis Via the NOD-like Receptor Pathway. | J Clin Immunol | 2025 | https://conductscience.org/library/papers/41291215 | PubMed |
| 41220006 | Protein acylation in inflammatory diseases: from mechanisms to therapeutic strategies. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41220006 | PubMed |
| 41019036 | IKZF1 exacerbates the inflammatory response by epigenetically modulating mitochondrial function following acute peritonitis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41019036 | PubMed |
| 40867911 | Epigenetic Regulation in Ischemic Neuroprotection: The Dual Role of HDACs and HATs in Neuroinflammation and Recovery. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40867911 | PubMed |
| 39092292 | Macrophage plasticity: signaling pathways, tissue repair, and regeneration. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39092292 | PubMed |
| 38696653 | Curcumin Equipped Nanozyme-Like Metal-Organic Framework Platform for the Targeted Atherosclerosis Treatment with Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38696653 | PubMed |
| 38641672 | The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/38641672 | PubMed |
| 38296798 | Emerging Roles of Macrophage Polarization in Osteoarthritis: Mechanisms and Therapeutic Strategies. | Orthop Surg | 2024 | https://conductscience.org/library/papers/38296798 | PubMed |
| 37891870 | Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37891870 | PubMed |
| 37726755 | Correction: Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37726755 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37598147
GET https://conductscience.org/api/papers/v1/37598147/references?page=2